0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peripheral Angioplasty and Stenting Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22E13027
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Peripheral Angioplasty and Stenting Market Research Report 2023
BUY CHAPTERS

Global Peripheral Angioplasty and Stenting Market Research Report 2025

Code: QYRE-Auto-22E13027
Report
March 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peripheral Angioplasty and Stenting Market Size

The global market for Peripheral Angioplasty and Stenting was valued at US$ 5095 million in the year 2024 and is projected to reach a revised size of US$ 7920 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Peripheral Angioplasty and Stenting Market

Peripheral Angioplasty and Stenting Market

Angioplasty is a procedure that uses a catheter and a balloon to open up blocked arteries. Stenting happens after angioplasty during which your surgeon inserts a small metal device in the artery. The stent helps keep the artery open and improve blood flow.
The Peripheral Angioplasty and Stenting market is driven by the increasing prevalence of peripheral arterial disease (PAD) and the need for effective minimally invasive treatment options. Angioplasty and stenting procedures are performed to restore blood flow in narrowed or blocked peripheral arteries. The rise in PAD cases and the demand for procedures that alleviate symptoms and improve quality of life contribute to market growth as patients seek less invasive alternatives to surgical interventions. Moreover, advancements in stent technology, including improved flexibility and drug-eluting options, align with better procedural outcomes. However, the market also faces challenges, including addressing vessel tortuosity and calcification that can complicate the procedure, and the need for long-term durability of stents. Additionally, gaining reimbursement approval and promoting awareness about PAD treatment benefits can pose obstacles for manufacturers. To succeed, companies must focus on technological innovation, collaborate with vascular specialists for procedural insights, and address the challenges to meet the increasing demand for effective and patient-centric peripheral angioplasty and stenting solutions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peripheral Angioplasty and Stenting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Angioplasty and Stenting.
The Peripheral Angioplasty and Stenting market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Angioplasty and Stenting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Angioplasty and Stenting manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peripheral Angioplasty and Stenting Market Report

Report Metric Details
Report Name Peripheral Angioplasty and Stenting Market
Accounted market size in year US$ 5095 million
Forecasted market size in 2031 US$ 7920 million
CAGR 6.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Balloon
  • Stent
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peripheral Angioplasty and Stenting manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peripheral Angioplasty and Stenting in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Peripheral Angioplasty and Stenting Market growing?

Ans: The Peripheral Angioplasty and Stenting Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Peripheral Angioplasty and Stenting Market size in 2031?

Ans: The Peripheral Angioplasty and Stenting Market size in 2031 will be US$ 7920 million.

Who are the main players in the Peripheral Angioplasty and Stenting Market report?

Ans: The main players in the Peripheral Angioplasty and Stenting Market are B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic

What are the Application segmentation covered in the Peripheral Angioplasty and Stenting Market report?

Ans: The Applications covered in the Peripheral Angioplasty and Stenting Market report are Hospitals, ASCs, Catheterization Laboratory

What are the Type segmentation covered in the Peripheral Angioplasty and Stenting Market report?

Ans: The Types covered in the Peripheral Angioplasty and Stenting Market report are Balloon, Stent

Recommended Reports

Peripheral Devices

Stent Technologies

Balloon & Catheters

1 Peripheral Angioplasty and Stenting Market Overview
1.1 Product Definition
1.2 Peripheral Angioplasty and Stenting by Type
1.2.1 Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2024 VS 2031)
1.2.2 Balloon
1.2.3 Stent
1.3 Peripheral Angioplasty and Stenting by Application
1.3.1 Global Peripheral Angioplasty and Stenting Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Peripheral Angioplasty and Stenting Market Size Estimates and Forecasts
1.4.1 Global Peripheral Angioplasty and Stenting Revenue 2020-2031
1.4.2 Global Peripheral Angioplasty and Stenting Sales 2020-2031
1.4.3 Global Peripheral Angioplasty and Stenting Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peripheral Angioplasty and Stenting Market Competition by Manufacturers
2.1 Global Peripheral Angioplasty and Stenting Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peripheral Angioplasty and Stenting Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peripheral Angioplasty and Stenting Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peripheral Angioplasty and Stenting, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Angioplasty and Stenting, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Angioplasty and Stenting, Product Type & Application
2.7 Global Key Manufacturers of Peripheral Angioplasty and Stenting, Date of Enter into This Industry
2.8 Global Peripheral Angioplasty and Stenting Market Competitive Situation and Trends
2.8.1 Global Peripheral Angioplasty and Stenting Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peripheral Angioplasty and Stenting Players Market Share by Revenue
2.8.3 Global Peripheral Angioplasty and Stenting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peripheral Angioplasty and Stenting Market Scenario by Region
3.1 Global Peripheral Angioplasty and Stenting Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peripheral Angioplasty and Stenting Sales by Region: 2020-2031
3.2.1 Global Peripheral Angioplasty and Stenting Sales by Region: 2020-2025
3.2.2 Global Peripheral Angioplasty and Stenting Sales by Region: 2026-2031
3.3 Global Peripheral Angioplasty and Stenting Revenue by Region: 2020-2031
3.3.1 Global Peripheral Angioplasty and Stenting Revenue by Region: 2020-2025
3.3.2 Global Peripheral Angioplasty and Stenting Revenue by Region: 2026-2031
3.4 North America Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.4.1 North America Peripheral Angioplasty and Stenting Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peripheral Angioplasty and Stenting Sales by Country (2020-2031)
3.4.3 North America Peripheral Angioplasty and Stenting Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.5.1 Europe Peripheral Angioplasty and Stenting Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peripheral Angioplasty and Stenting Sales by Country (2020-2031)
3.5.3 Europe Peripheral Angioplasty and Stenting Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Angioplasty and Stenting Market Facts & Figures by Region
3.6.1 Asia Pacific Peripheral Angioplasty and Stenting Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peripheral Angioplasty and Stenting Sales by Region (2020-2031)
3.6.3 Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.7.1 Latin America Peripheral Angioplasty and Stenting Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peripheral Angioplasty and Stenting Sales by Country (2020-2031)
3.7.3 Latin America Peripheral Angioplasty and Stenting Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Angioplasty and Stenting Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Angioplasty and Stenting Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peripheral Angioplasty and Stenting Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peripheral Angioplasty and Stenting Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peripheral Angioplasty and Stenting Sales by Type (2020-2031)
4.1.1 Global Peripheral Angioplasty and Stenting Sales by Type (2020-2025)
4.1.2 Global Peripheral Angioplasty and Stenting Sales by Type (2026-2031)
4.1.3 Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2020-2031)
4.2 Global Peripheral Angioplasty and Stenting Revenue by Type (2020-2031)
4.2.1 Global Peripheral Angioplasty and Stenting Revenue by Type (2020-2025)
4.2.2 Global Peripheral Angioplasty and Stenting Revenue by Type (2026-2031)
4.2.3 Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2020-2031)
4.3 Global Peripheral Angioplasty and Stenting Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peripheral Angioplasty and Stenting Sales by Application (2020-2031)
5.1.1 Global Peripheral Angioplasty and Stenting Sales by Application (2020-2025)
5.1.2 Global Peripheral Angioplasty and Stenting Sales by Application (2026-2031)
5.1.3 Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2020-2031)
5.2 Global Peripheral Angioplasty and Stenting Revenue by Application (2020-2031)
5.2.1 Global Peripheral Angioplasty and Stenting Revenue by Application (2020-2025)
5.2.2 Global Peripheral Angioplasty and Stenting Revenue by Application (2026-2031)
5.2.3 Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2020-2031)
5.3 Global Peripheral Angioplasty and Stenting Price by Application (2020-2031)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Company Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.1.4 B. Braun Peripheral Angioplasty and Stenting Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Peripheral Angioplasty and Stenting Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Peripheral Angioplasty and Stenting Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Peripheral Angioplasty and Stenting Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi
6.5.1 Yinyi Company Information
6.5.2 Yinyi Description and Business Overview
6.5.3 Yinyi Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yinyi Peripheral Angioplasty and Stenting Product Portfolio
6.5.5 Yinyi Recent Developments/Updates
6.6 Philips
6.6.1 Philips Company Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Philips Peripheral Angioplasty and Stenting Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 Eurocor
6.7.1 Eurocor Company Information
6.7.2 Eurocor Description and Business Overview
6.7.3 Eurocor Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eurocor Peripheral Angioplasty and Stenting Product Portfolio
6.7.5 Eurocor Recent Developments/Updates
6.8 Aachen Resonance
6.8.1 Aachen Resonance Company Information
6.8.2 Aachen Resonance Description and Business Overview
6.8.3 Aachen Resonance Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolio
6.8.5 Aachen Resonance Recent Developments/Updates
6.9 Biotronic
6.9.1 Biotronic Company Information
6.9.2 Biotronic Description and Business Overview
6.9.3 Biotronic Peripheral Angioplasty and Stenting Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biotronic Peripheral Angioplasty and Stenting Product Portfolio
6.9.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Angioplasty and Stenting Industry Chain Analysis
7.2 Peripheral Angioplasty and Stenting Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Angioplasty and Stenting Production Mode & Process Analysis
7.4 Peripheral Angioplasty and Stenting Sales and Marketing
7.4.1 Peripheral Angioplasty and Stenting Sales Channels
7.4.2 Peripheral Angioplasty and Stenting Distributors
7.5 Peripheral Angioplasty and Stenting Customer Analysis
8 Peripheral Angioplasty and Stenting Market Dynamics
8.1 Peripheral Angioplasty and Stenting Industry Trends
8.2 Peripheral Angioplasty and Stenting Market Drivers
8.3 Peripheral Angioplasty and Stenting Market Challenges
8.4 Peripheral Angioplasty and Stenting Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peripheral Angioplasty and Stenting Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peripheral Angioplasty and Stenting Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peripheral Angioplasty and Stenting Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Peripheral Angioplasty and Stenting Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peripheral Angioplasty and Stenting Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peripheral Angioplasty and Stenting Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peripheral Angioplasty and Stenting, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Product Type & Application
 Table 12. Global Key Manufacturers of Peripheral Angioplasty and Stenting, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peripheral Angioplasty and Stenting by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Angioplasty and Stenting as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peripheral Angioplasty and Stenting Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peripheral Angioplasty and Stenting Sales by Region (2020-2025) & (K Units)
 Table 18. Global Peripheral Angioplasty and Stenting Sales Market Share by Region (2020-2025)
 Table 19. Global Peripheral Angioplasty and Stenting Sales by Region (2026-2031) & (K Units)
 Table 20. Global Peripheral Angioplasty and Stenting Sales Market Share by Region (2026-2031)
 Table 21. Global Peripheral Angioplasty and Stenting Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peripheral Angioplasty and Stenting Revenue Market Share by Region (2020-2025)
 Table 23. Global Peripheral Angioplasty and Stenting Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peripheral Angioplasty and Stenting Revenue Market Share by Region (2026-2031)
 Table 25. North America Peripheral Angioplasty and Stenting Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peripheral Angioplasty and Stenting Sales by Country (2020-2025) & (K Units)
 Table 27. North America Peripheral Angioplasty and Stenting Sales by Country (2026-2031) & (K Units)
 Table 28. North America Peripheral Angioplasty and Stenting Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peripheral Angioplasty and Stenting Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peripheral Angioplasty and Stenting Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peripheral Angioplasty and Stenting Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Peripheral Angioplasty and Stenting Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Peripheral Angioplasty and Stenting Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peripheral Angioplasty and Stenting Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peripheral Angioplasty and Stenting Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Peripheral Angioplasty and Stenting Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peripheral Angioplasty and Stenting Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peripheral Angioplasty and Stenting Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peripheral Angioplasty and Stenting Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Peripheral Angioplasty and Stenting Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Peripheral Angioplasty and Stenting Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peripheral Angioplasty and Stenting Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peripheral Angioplasty and Stenting Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peripheral Angioplasty and Stenting Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Peripheral Angioplasty and Stenting Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Peripheral Angioplasty and Stenting Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peripheral Angioplasty and Stenting Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peripheral Angioplasty and Stenting Sales (K Units) by Type (2020-2025)
 Table 51. Global Peripheral Angioplasty and Stenting Sales (K Units) by Type (2026-2031)
 Table 52. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2020-2025)
 Table 53. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2026-2031)
 Table 54. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2020-2025)
 Table 57. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2026-2031)
 Table 58. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Peripheral Angioplasty and Stenting Sales (K Units) by Application (2020-2025)
 Table 61. Global Peripheral Angioplasty and Stenting Sales (K Units) by Application (2026-2031)
 Table 62. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2020-2025)
 Table 63. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2026-2031)
 Table 64. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peripheral Angioplasty and Stenting Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2020-2025)
 Table 67. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2026-2031)
 Table 68. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2026-2031)
 Table 70. B. Braun Company Information
 Table 71. B. Braun Description and Business Overview
 Table 72. B. Braun Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. B. Braun Peripheral Angioplasty and Stenting Product
 Table 74. B. Braun Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Peripheral Angioplasty and Stenting Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Boston Scientific Company Information
 Table 81. Boston Scientific Description and Business Overview
 Table 82. Boston Scientific Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boston Scientific Peripheral Angioplasty and Stenting Product
 Table 84. Boston Scientific Recent Developments/Updates
 Table 85. BD Company Information
 Table 86. BD Description and Business Overview
 Table 87. BD Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. BD Peripheral Angioplasty and Stenting Product
 Table 89. BD Recent Developments/Updates
 Table 90. Yinyi Company Information
 Table 91. Yinyi Description and Business Overview
 Table 92. Yinyi Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Yinyi Peripheral Angioplasty and Stenting Product
 Table 94. Yinyi Recent Developments/Updates
 Table 95. Philips Company Information
 Table 96. Philips Description and Business Overview
 Table 97. Philips Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Philips Peripheral Angioplasty and Stenting Product
 Table 99. Philips Recent Developments/Updates
 Table 100. Eurocor Company Information
 Table 101. Eurocor Description and Business Overview
 Table 102. Eurocor Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Eurocor Peripheral Angioplasty and Stenting Product
 Table 104. Eurocor Recent Developments/Updates
 Table 105. Aachen Resonance Company Information
 Table 106. Aachen Resonance Description and Business Overview
 Table 107. Aachen Resonance Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Aachen Resonance Peripheral Angioplasty and Stenting Product
 Table 109. Aachen Resonance Recent Developments/Updates
 Table 110. Biotronic Company Information
 Table 111. Biotronic Description and Business Overview
 Table 112. Biotronic Peripheral Angioplasty and Stenting Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Biotronic Peripheral Angioplasty and Stenting Product
 Table 114. Biotronic Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Peripheral Angioplasty and Stenting Distributors List
 Table 118. Peripheral Angioplasty and Stenting Customers List
 Table 119. Peripheral Angioplasty and Stenting Market Trends
 Table 120. Peripheral Angioplasty and Stenting Market Drivers
 Table 121. Peripheral Angioplasty and Stenting Market Challenges
 Table 122. Peripheral Angioplasty and Stenting Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peripheral Angioplasty and Stenting
 Figure 2. Global Peripheral Angioplasty and Stenting Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peripheral Angioplasty and Stenting Market Share by Type: 2024 & 2031
 Figure 4. Balloon Product Picture
 Figure 5. Stent Product Picture
 Figure 6. Global Peripheral Angioplasty and Stenting Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peripheral Angioplasty and Stenting Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. ASCs
 Figure 10. Catheterization Laboratory
 Figure 11. Global Peripheral Angioplasty and Stenting Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Peripheral Angioplasty and Stenting Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Peripheral Angioplasty and Stenting Sales (2020-2031) & (K Units)
 Figure 14. Global Peripheral Angioplasty and Stenting Average Price (US$/Unit) & (2020-2031)
 Figure 15. Peripheral Angioplasty and Stenting Report Years Considered
 Figure 16. Peripheral Angioplasty and Stenting Sales Share by Manufacturers in 2024
 Figure 17. Global Peripheral Angioplasty and Stenting Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Peripheral Angioplasty and Stenting Players: Market Share by Revenue in Peripheral Angioplasty and Stenting in 2024
 Figure 19. Peripheral Angioplasty and Stenting Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Peripheral Angioplasty and Stenting Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Peripheral Angioplasty and Stenting Sales Market Share by Country (2020-2031)
 Figure 22. North America Peripheral Angioplasty and Stenting Revenue Market Share by Country (2020-2031)
 Figure 23. United States Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country (2020-2031)
 Figure 26. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Peripheral Angioplasty and Stenting Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Peripheral Angioplasty and Stenting Revenue Market Share by Region (2020-2031)
 Figure 34. China Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Peripheral Angioplasty and Stenting Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Peripheral Angioplasty and Stenting Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Peripheral Angioplasty and Stenting Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Peripheral Angioplasty and Stenting Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Peripheral Angioplasty and Stenting by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Peripheral Angioplasty and Stenting by Type (2020-2031)
 Figure 55. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Peripheral Angioplasty and Stenting by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Peripheral Angioplasty and Stenting by Application (2020-2031)
 Figure 58. Global Peripheral Angioplasty and Stenting Price (US$/Unit) by Application (2020-2031)
 Figure 59. Peripheral Angioplasty and Stenting Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String